MELISSA HAMILTON: Open Payments
NPI 1659509792 · WEST MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348 in 20 payments from 10 companies in 2025. Trend: 2023 $177 · 2024 $85 · 2025 $348
Food & beverage: $296Education: $52
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 6 | $130 |
| OPKO Pharmaceuticals, LLC | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $18 |
| Ardelyx, Inc. | 1 | $18 |
| Travere Therapeutics, Inc. | 3 | $17 |
| Amgen Inc. | 1 | $17 |
Products named: VELPHORO, RAYALDEE, VOYXACT, Kerendia, Rybelsus, LOKELMA, TREMFYA, IBSRELA.
Industry payments across LA — which companies pay providers there.
